Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

professional complementary health formulas - pygeum africanum 2x sabal serrulata 2x bee pollen 3x zincum metallicum 3x prostate 6x pulsatilla 12x tuberculinum 30x, 100x - for the temporary relief of difficult urination, excessive or frequent urge to urinate, or mild discomfort in the groin or genitals.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

newton laboratories, inc. - thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), cinchona officinalis bark (unii: s003a158sb) (cinchona officinali - thyroid, unspecified 15 [hp_x] in 1 g - prostate   formulated for symptoms associated with erectile dysfunction, benign prostatic hypertrophy, prostatitis, dysuria and other prostate related conditions. formulated for symptoms associated with erectile dysfunction, benign prostatic hypertrophy, prostatitis, dysuria and other prostate related conditions.

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

newton laboratories, inc. - thyroid, unspecified (unii: 0b4fdl9i6p) (thyroid, unspecified - unii:0b4fdl9i6p), barium carbonate (unii: 6p669d8hq8) (barium cation - unii:v645272hln), berberis vulgaris root bark (unii: 1th8q20j0u) (berberis vulgaris root bark - unii:1th8q20j0u), bryonia alba root (unii: t7j046yi2b) (bryonia alba root - unii:t7j046yi2b), oyster shell calcium carbonate, crude (unii: 2e32821g6i) (oyster shell calcium carbonate, crude - unii:2e32821g6i), cinchona officinalis bark (unii: s003a158sb) (cinchona officinali - thyroid, unspecified 15 [hp_x] in 1 ml - prostate   formulated for symptoms associated with erectile dysfunction, benign prostatic hypertrophy, prostatitis, dysuria and other prostate related conditions. formulated for symptoms associated with erectile dysfunction, benign prostatic hypertrophy, prostatitis, dysuria and other prostate related conditions.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct846 - prostate specific marker ivds - for in vitro diagnostic use in the determination of prostate specific markers in clinical specimens.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

roche diagnostics australia pty limited - ct846 - prostate specific marker ivds - the elecsys total and free psa immunoassays, are quantitative in vitro diagnostic tests for total (free + complexed) as well as free prostate-specific antigen in human serum and plasma, are indicated for the measurement of psa in conjunction with digital rectal examination (dre) as an aid in the detection of prostate cancer in men aged 50 years or older. prostate biopsy is required for diagnosis of prostate cancer. the tests are further indicated for serial measurement of psa to aid in the management of cancer patients. the electrochemiluminescence immunoassay ?eclia? is intended for use on elecsys and cobas e immunoassay analyzers. gmdns code and description: prostate specific marker ivds[ct846]

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

teleflex medical australia pty ltd - 58882 - prostatic retraction implant - the urolift system is intended for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (bph) in men over the age of 50.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct846 - prostate specific marker ivds - for in vitro diagnostic use in the quantitative and/or qualitative determination of prostate specific markers in a clinical specimen. these measurements are used in conjunction with other diagnostic procedures to aid in patient management.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

siemens healthcare pty ltd - ct846 - prostate specific marker ivds - for in vitro diagnostic use in the quantitative and/or qualitative determination of prostate specific markers in a clinical specimen.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

ortho-clinical diagnostics australia pty ltd - ct846 - prostate specific marker ivds - ivds that are intended to be used for the qualitative and/or quantitative determination of prostate specific markers in a clinical specimen.

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

beckman coulter australia pty ltd - ct846 - prostate specific marker ivds - access hybritech p2psa kit, controls and calibrators are a paramagnetic particle, chemiluminescent assay used in combination with the access hybritech psa and free psa assays to calculate the beckman coulter phi, a multivariate index, intended to aid the determination of the risk of prostate cancer using human serum on the access immunoassay systems.